Paracrine recruitment and activation of fibroblasts by c‐Myc expressing breast epithelial cells through the IGFs/IGF‐1R axis

Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms

(2017) C Unger et al.   ONCOGENE

Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression

(2017) Wen Wen Xu et al.   Nature Communications

MYC Deregulation in Primary Human Cancers

(2017) Manpreet Kalkat et al.   Genes

The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas

(2016) Yoshihiro Mezawa et al.   CELL AND TISSUE RESEARCH

Fibroblast activation in cancer: when seed fertilizes soil

(2016) Sanya-Eduarda Kuzet et al.   CELL AND TISSUE RESEARCH

Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade

(2015) W. T. Iams et al.   CLINICAL CANCER RESEARCH

The role of the insulin-like growth factor-1 system in breast cancer

(2015) Panagiotis F Christopoulos et al.   Molecular Cancer

Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts

(2015) Jean Albrengues et al.   Nature Communications

FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells

(2015) LaTonia Taliaferro-Smith et al.   Oncotarget

Insidious Changes in Stromal Matrix Fuel Cancer Progression

(2014) Fayth L. Miles et al.   MOLECULAR CANCER RESEARCH

Physical influences of the extracellular environment on cell migration

(2014) Guillaume Charras et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Loss of Stromal Caveolin-1 Expression: A Novel Tumor Microenvironment Biomarker That Can Predict Poor Clinical Outcomes for Pancreatic Cancer

(2014) Tao Shan et al.   PLoS One

Tumour Microenvironments Induce Expression of Urokinase Plasminogen Activator Receptor (uPAR) and Concomitant Activation of Gelatinolytic Enzymes

(2014) Synnøve Magnussen et al.   PLoS One

Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling

(2014) Wan-Jiun Chen et al.   Nature Communications

MYC Activation Is a Hallmark of Cancer Initiation and Maintenance

(2014) M. Gabay et al.   Cold Spring Harbor Perspectives in Medicine

Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment

(2014) Martin Augsten   Frontiers in Oncology

Opposite Modulation of Cell Migration by Distinct Subregions of Urokinase Connecting Peptide

(2013) Paola Franco et al.   CHEMBIOCHEM

IGF2 and cancer

(2013) Callum Livingstone   ENDOCRINE-RELATED CANCER

Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort

(2013) Rudolf Kaaks et al.   INTERNATIONAL JOURNAL OF CANCER

Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic

(2013) Maha A Al-Rakan et al.   JOURNAL OF PATHOLOGY

Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts

(2013) Fernando Calvo et al.   NATURE CELL BIOLOGY

TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer

(2013) S Busch et al.   ONCOGENE

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

Insulin-like growth factor-binding protein-6 and cancer

(2012) Leon A. Bach et al.   CLINICAL SCIENCE

miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling

(2012) C A Gebeshuber et al.   ONCOGENE

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

(2011) Peter Friedl et al.   CELL

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Regulation of Cell Migration and Invasion by Specific Modules of uPA: Mechanistic Insights and Specific Inhibitors

(2011) Maria Vincenza Carriero et al.   CURRENT DRUG TARGETS

The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling

(2011) Maria Vincenza Carriero et al.   CURRENT PHARMACEUTICAL DESIGN

Analysis of Secretome Changes Uncovers an Autocrine/Paracrine Component in the Modulation of Cell Proliferation and Motility by c-Myc

(2011) Gabriella Pocsfalvi et al.   JOURNAL OF PROTEOME RESEARCH

IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients

(2010) Michal Rajski et al.   BMC Medicine

Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro

(2010) M.-Q. Gao et al.   JOURNAL OF CELL SCIENCE

Modulation of Cellular Migration and Survival by c-Myc through the Downregulation of Urokinase (uPA) and uPA Receptor

(2010) D. Alfano et al.   MOLECULAR AND CELLULAR BIOLOGY

Autocrine TGF-  and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts

(2010) Y. Kojima et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting of the protein interaction site between FAK and IGF-1R

(2009) Donghang Zheng et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of αvβ5 integrin activation

(2008) Immacolata Vocca et al.   INTERNATIONAL JOURNAL OF CANCER

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols